{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=89", "query": { "intervention": "Part 1", "page": 89 }, "page_size": 10 }, "pagination": { "page": 89, "page_size": 10, "total_count": 6233, "total_pages": 624, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=90&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Part+1&page=88&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-14T20:25:24.250Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00054665", "title": "PS-341 Alone and PS-341 Plus EPOCH Chemotherapy to Treat Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "B-Cell Lymphoma" ], "interventions": [ { "name": "PS-341", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Filgrastim", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2003-02", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2012-09-11", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 2, "location_summary": "Bethesda, Maryland • Buffalo, New York", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00054665" }, { "nct_id": "NCT05369000", "title": "Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Metastatic Castration Resistant Prostate Cancer" ], "interventions": [ { "name": "LAVA-1207", "type": "BIOLOGICAL" }, { "name": "LAVA-1207 plus Pembrolizumab", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Lava Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 96, "start_date": "2022-01-17", "completion_date": "2025-06-18", "has_results": false, "last_update_posted_date": "2025-08-01", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 6, "location_summary": "San Francisco, California • Minneapolis, Minnesota • St Louis, Missouri + 3 more", "locations": [ { "city": "San Francisco", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "St Louis", "state": "Missouri" }, { "city": "New York", "state": "New York" }, { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05369000" }, { "nct_id": "NCT02942264", "title": "Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Brain Tumor", "Astrocytoma", "Astroglioma", "Glioblastoma", "Gliosarcoma" ], "interventions": [ { "name": "Zotiraciclib (TG02)", "type": "DRUG" }, { "name": "Temozolomide (TMZ)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 53, "start_date": "2016-12-14", "completion_date": "2020-08-26", "has_results": true, "last_update_posted_date": "2026-02-23", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02942264" }, { "nct_id": "NCT02875925", "title": "Outcomes Study of MTM in a Medicare ACO", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Hypoglycemia" ], "interventions": [ { "name": "MTM", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "HealthEast Care System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "66 Years", "maximum_age": null, "sex": "ALL", "summary": "66 Years and older" }, "enrollment_count": 77, "start_date": "2015-12", "completion_date": "2017-12", "has_results": false, "last_update_posted_date": "2018-02-27", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 1, "location_summary": "Saint Paul, Minnesota", "locations": [ { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02875925" }, { "nct_id": "NCT03087617", "title": "Personalized Smoking Cessation Tool Based on Patient Lung CT Image", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Smoking Cessation" ], "interventions": [ { "name": "Imbio Smoking Cessation Report", "type": "DEVICE" }, { "name": "Smoking Cessation Counseling", "type": "BEHAVIORAL" }, { "name": "Usual Care", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "BEHAVIORAL", "OTHER" ], "sponsor": "Imbio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "55 Years to 80 Years" }, "enrollment_count": 321, "start_date": "2018-10-03", "completion_date": "2021-08-23", "has_results": true, "last_update_posted_date": "2022-10-05", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03087617" }, { "nct_id": "NCT01992874", "title": "Relative Bioavailability of Pimasertib in Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neoplasms" ], "interventions": [ { "name": "Pimasertib Capsule (Part A)", "type": "DRUG" }, { "name": "Pimasertib Tablet (Part A)", "type": "DRUG" }, { "name": "Pimasertib Capsule (Part B and trial extension phase)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "EMD Serono", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 38, "start_date": "2013-11-30", "completion_date": "2015-02-28", "has_results": true, "last_update_posted_date": "2017-08-15", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 1, "location_summary": "Rockland, Massachusetts", "locations": [ { "city": "Rockland", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01992874" }, { "nct_id": "NCT04575597", "title": "Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Coronavirus Disease (COVID-19)" ], "interventions": [ { "name": "Molnupiravir", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1735, "start_date": "2020-10-19", "completion_date": "2022-05-05", "has_results": true, "last_update_posted_date": "2023-06-28", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 32, "location_summary": "Peoria, Arizona • Los Angeles, California • North Hollywood, California + 27 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "North Hollywood", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04575597" }, { "nct_id": "NCT07560813", "title": "NOURISH - A Healthcare-community Partnership to Improve Nutrition for Optimal Glycemic Control and Pregnancy Outcomes With Pregestational Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes", "Type 1 Diabetes", "Pregnancy, High Risk" ], "interventions": [ { "name": "Mid-Ohio Food Farmacy (MOF+) produce delivery", "type": "DIETARY_SUPPLEMENT" }, { "name": "Nutrition education with Dining with Diabetes (DWD)", "type": "BEHAVIORAL" }, { "name": "Health Impact Ohio Central Ohio Pathways Hub to address unmet social needs", "type": "BEHAVIORAL" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "BEHAVIORAL" ], "sponsor": "Ohio State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 174, "start_date": "2026-07-06", "completion_date": "2030-06-30", "has_results": false, "last_update_posted_date": "2026-08-14", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT07560813" }, { "nct_id": "NCT04958226", "title": "A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Solid Tumour" ], "interventions": [ { "name": "Capivasertib", "type": "DRUG" }, { "name": "Midazolam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 21, "start_date": "2021-10-15", "completion_date": "2023-02-15", "has_results": false, "last_update_posted_date": "2024-01-25", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 5, "location_summary": "Aurora, Colorado • Durham, North Carolina • Cleveland, Ohio + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Durham", "state": "North Carolina" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04958226" }, { "nct_id": "NCT03741608", "title": "B'More for a Peaceful Motherhood Hypertension Control Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "High blood pressure management education", "type": "BEHAVIORAL" }, { "name": "Home blood pressure measurement", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Maryland, Baltimore", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "18 Years to 44 Years · Female only" }, "enrollment_count": 23, "start_date": "2019-01-22", "completion_date": "2020-04-01", "has_results": false, "last_update_posted_date": "2021-04-14", "last_synced_at": "2026-11-14T20:25:24.250Z", "location_count": 4, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03741608" } ] }